• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker].

作者信息

Portilla Alfredo, Torres Daniel, Machado-Duque Manuel Enrique, Machado-Alba Jorge Enrique

机构信息

Audifarma S.A, Pereira, Colombia.

Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.

出版信息

Aten Primaria. 2016 Apr;48(4):272-4. doi: 10.1016/j.aprim.2015.07.004. Epub 2015 Oct 29.

DOI:10.1016/j.aprim.2015.07.004
PMID:26522784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6877824/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8211/6877824/9e18ab0776d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8211/6877824/9e18ab0776d6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8211/6877824/9e18ab0776d6/gr1.jpg

相似文献

1
[Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker].[血管紧张素转换酶抑制剂与血管紧张素 II 受体阻滞剂联合用药处方的干预措施]
Aten Primaria. 2016 Apr;48(4):272-4. doi: 10.1016/j.aprim.2015.07.004. Epub 2015 Oct 29.
2
Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.药师干预对糖尿病患者使用血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体阻滞剂和阿司匹林的影响。
Am J Health Syst Pharm. 2010 Feb 15;67(4):290-4. doi: 10.2146/ajhp090009.
3
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.报告估算肾小球滤过率与 CKD 患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的使用增加有关。
Kidney Int. 2012 Jun;81(12):1248-53. doi: 10.1038/ki.2012.18. Epub 2012 Mar 21.
4
Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity.血管紧张素转换酶与血管紧张素受体阻滞剂联合治疗对心力衰竭死亡率和发病率的影响。
Am J Cardiol. 2008 Mar 1;101(5):744-5. doi: 10.1016/j.amjcard.2007.10.013.
5
Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.两个是否比一个更好？血管紧张素转换酶抑制剂加血管紧张素受体阻滞剂用于降低肾病患者的血压和蛋白尿
Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S17-23. doi: 10.2215/CJN.03270807.
6
Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.对非糖尿病肾病试验结果中血管紧张素II受体阻滞剂与血管紧张素转换酶抑制剂联合治疗的盲目接受。
Hypertension. 2009 Jan;53(1):e3; author reply e4. doi: 10.1161/HYPERTENSIONAHA.108.125062. Epub 2008 Dec 1.
7
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.阿利吉仑与噻嗪类利尿剂、血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂联合使用时，可降低血压并抑制血浆肾素活性。
Hypertension. 2007 Feb;49(2):276-84. doi: 10.1161/01.HYP.0000253780.36691.4f. Epub 2006 Dec 11.
8
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.肾素-血管紧张素-醛固酮系统三联阻断对非糖尿病肾病的影响：在血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂联合治疗基础上加用醛固酮拮抗剂螺内酯
Hypertens Res. 2008 Jan;31(1):59-67. doi: 10.1291/hypres.31.59.
9
Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.高血压中血管紧张素转换酶抑制与血管紧张素受体阻滞剂联合应用的系统评价
Hypertension. 2005 May;45(5):880-6. doi: 10.1161/01.HYP.0000161880.59963.da. Epub 2005 Apr 4.
10
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: new therapeutic world beyond blood pressure reduction.慢性肾病中血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂的联合治疗：降压之外的新治疗领域。
Kidney Int. 2005 Sep;68(3):1375-6. doi: 10.1038/ki.2005.4496234.

引用本文的文献

1
Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.减少养老院居民潜在不适当的药物处方：老年干预的效果。
Br J Clin Pharmacol. 2018 Jul;84(7):1598-1610. doi: 10.1111/bcp.13598. Epub 2018 May 14.
2
Endpoints in strategies to reduce polypharmacy.减少多重用药策略中的终点指标。
Br J Clin Pharmacol. 2017 Feb;83(2):432-433. doi: 10.1111/bcp.13122. Epub 2016 Sep 29.

本文引用的文献

1
[Quality of conventional release verapamil prescription in patients with arterial hypertension].[高血压患者常规释放维拉帕米处方的质量]
Rev Calid Asist. 2015 Mar-Apr;30(2):72-8. doi: 10.1016/j.cali.2015.01.009. Epub 2015 Mar 3.
2
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).2014 年成人高血压管理的循证指南：第八届联合国家委员会（JNC 8）任命的专家组报告。
JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427.
3
Pharmacoepidemiology.
药物流行病学
Br J Clin Pharmacol. 2012 Jun;73(6):973-8. doi: 10.1111/j.1365-2125.2012.04248.x.
4
Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations.肾素-血管紧张素-醛固酮系统阻断：没有充分理由联合使用 ACEI 和 ARB。
Am J Med. 2011 Jan;124(1):15-9. doi: 10.1016/j.amjmed.2010.07.021.
5
Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.双肾素-血管紧张素-醛固酮系统阻断剂治疗心血管疾病的现状。
Am J Cardiol. 2010 Mar 15;105(6):849-52. doi: 10.1016/j.amjcard.2009.11.044.
6
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.使用血管紧张素受体阻滞剂（ARB）和血管紧张素转换酶抑制剂（ACEI）进行肾素-血管紧张素系统（RAS）阻断：关于理论依据和患者选择的当前观点
Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3.